Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,577,556
-$733,410 QoQ
Shares Held
2,530
-15.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#561
of 1,322 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $18,605,643 across 285 Biotechnology names. REGN ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
37,664 | $2,947,961 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,487 | $2,228,827 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,562 | $1,912,615 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,530 | $1,577,556 | |
| 5 | INCY |
Incyte Corp
|
5,182 | $587,431 | |
| 6 | EXEL |
Exelixis, Inc.
|
10,562 | $574,678 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
10,089 | $550,254 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2,240 | $419,507 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,577,556 | 2,530 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,310,966 | 2,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,684,992 | 2,183 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $841,155 | 1,496 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $521,850 | 994 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $520,702 | 821 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $682,412 | 958 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $745,329 | 709 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $694,730 | 661 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $508,194 | 528 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $317,940 | 362 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $294,618 | 358 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $245,740 | 342 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $133,932 | 163 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $100,287 | 139 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $88,864 | 129 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $54,383 | 92 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $32,825 | 47 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $34,733 | 55 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $19,365 | 32 | Shares | Sole | 2021-11-02 | |
| 2021-03-31 | $17,033 | 36 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $17,391 | 36 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $20,152 | 36 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $22,451 | 36 | Shares | Sole | 2020-07-24 | |
| No filing history on record for this holder in this stock. | ||||||